Intracerebral hemorrhage: the next frontier for minimally invasive stroke treatment

Great technical, scientific, and clinical advances have been made in the treatment of both emergent large vessel occlusions (ELVOs) and cerebral aneurysms. However, little progress has been made in the management of patients with primary intracerebral hemorrhage (ICH)—the leading cause of hemorrhagic stroke.1 ICH accounts for 10–15% of all strokes and is associated with the highest rates of morbidity and mortality of all stroke subtypes.1 2 Almost half of afflicted patients do not survive and only 20% of survivors are independent at 180 days.3 4 No medical interventions, with the exception of blood pressure management and anticoagulation reversal, have been shown to improve outcomes for these patients, and even for these treatments, evidence is conflicting.5–8 Two large randomized controlled trials (RCTs) evaluating open craniotomy for ICH did not show significant improvements in...
Source: Journal of NeuroInterventional Surgery - Category: Neurosurgery Authors: Tags: Editor ' s column Source Type: research